Novuspharma S.p.A. is a Biopharma company that leverages its expertise in the field of oncology to discover and develop innovative new treatments for cancer. The Company was based in Bresso (Milan), Italy, Novuspharma began operations in 1999, following its spin-off from Boehringer Mannheim and Hoffmann-La Roche. The company was spun-out in order to exploit the research and development team’s expertise in the field of cancer research. The Company has a broad and diverse product portfolio and a rich research pipelin including new generations of existing therapies and completely novel classes of pharmaceutical agents. Novuspharma merged into Cell Therapeutics which is listed on the NASDAQ [CTI] in 2004.